A retrospective, cohort study to describe the adherence to three direct oral anticoagulants (dabigatran, rivaroxaban, apixaban) in patients with non-valvular atrial fibrillation
Latest Information Update: 09 Sep 2019
At a glance
- Drugs Apixaban (Primary) ; Dabigatran etexilate (Primary) ; Rivaroxaban (Primary)
- Indications Cardiovascular disorders; Thromboembolism
- Focus Therapeutic Use
Most Recent Events
- 09 Sep 2019 New trial record